alirezaghoreifi Profile Banner
Alireza Ghoreifi, MD Profile
Alireza Ghoreifi, MD

@alirezaghoreifi

Followers
1K
Following
5K
Media
302
Statuses
1K

@UroOnc Fellow @DukeUrology| @USC_Urology alumni| Social Media Editor @UrolOncol |@SIU_urology Innovators Committee| ECEB @Current_Urology ⚽️🎬🎼

Raleigh, NC
Joined September 2013
Don't wanna be here? Send us removal request.
@alirezaghoreifi
Alireza Ghoreifi, MD
6 days
RT @GUconference: Physicians, APPs, Nurses, Pharmacists: Don’t wait. #WorldGU25 is next month. Join 60+ experts in Nashville, TN, Aug 21–23….
0
1
0
@alirezaghoreifi
Alireza Ghoreifi, MD
6 days
RT @UrolOncol: 📢New in @UrolOncol!. Highlights:.▶️Lower preop step counts↔️dc to SNF.▶️Lower in-hospital activity↔️dc to SNF .▶️Lower preop….
0
7
0
@alirezaghoreifi
Alireza Ghoreifi, MD
8 days
Honored to be one of the @GUconference poster winners! Grateful to my mentor @michaelabern and our amazing team @JuddMoul @Davicioni @DukeGUCancer @DukeUrology.
@GUconference
World GU Conference
8 days
Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits.
Tweet media one
2
1
17
@alirezaghoreifi
Alireza Ghoreifi, MD
9 days
RT @UrolOncol: 🔥The August 2025 issue of 'Urologic Oncology: Seminars and Original Investigations' is now available. Unlock the latest in….
0
1
0
@alirezaghoreifi
Alireza Ghoreifi, MD
10 days
RT @urotoday: Registry data shows risk migration with blue light cystoscopy. @alirezaghoreifi @DukeUrology & @siadaneshmand @KECKSchool_USC….
0
6
0
@alirezaghoreifi
Alireza Ghoreifi, MD
10 days
RT @UrologyTimes: In this video, @AnneSchuckmanMD outlines current challenges in NMIBC care #urology #bladdercancer….
0
2
0
@alirezaghoreifi
Alireza Ghoreifi, MD
11 days
RT @alirezaghoreifi: New from the ROBUUST group in @Cancers_MDPI .@FarshadSheybaee @Hoomandjaladat .#UTUC #Immunotherapy . 🔗Free link acces….
0
12
0
@alirezaghoreifi
Alireza Ghoreifi, MD
13 days
RT @urotoday: Nadofaragene firadenovec treatment updates for BCG-unresponsive #BladderCancer. @AnneSchuckmanMD @KeckMedicineUSC joins @UroD….
0
5
0
@alirezaghoreifi
Alireza Ghoreifi, MD
13 days
RT @siadaneshmand: What a fantastic tool! Thanks for sharing. @KariTikkinen @GU_BigWhacks @saumyg @VigneshPackiam @UroAlsyouf @douglawi @Le….
0
7
0
@alirezaghoreifi
Alireza Ghoreifi, MD
14 days
RT @siadaneshmand: Should #radicalcystectomy ever be considered for consolidate therapy post EV/P?@PGrivasMDPhD @sh….
0
28
0
@alirezaghoreifi
Alireza Ghoreifi, MD
14 days
Tweet media one
1
6
34
@alirezaghoreifi
Alireza Ghoreifi, MD
15 days
RT @bbmdmsk: A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgi….
0
30
0
@alirezaghoreifi
Alireza Ghoreifi, MD
17 days
RT @ALDCAbreu: Important data on focal therapy for prostate cancer. 🎯 ☢️ 🤖 . Great job as always @alirezaghoreifi @lorenzormc and @KanekoMa….
0
10
0
@alirezaghoreifi
Alireza Ghoreifi, MD
20 days
New from the ROBUUST group in @Cancers_MDPI .@FarshadSheybaee @Hoomandjaladat .#UTUC #Immunotherapy . 🔗Free link access:
Tweet media one
0
12
45
@alirezaghoreifi
Alireza Ghoreifi, MD
22 days
RT @EUplatinum: 📘 Just published in European Urology:. 🔄 The 2025 EAU Guidelines on UTUC are here!. 🧬 Major updates include:.• Revised risk….
0
44
0
@alirezaghoreifi
Alireza Ghoreifi, MD
28 days
Congratulations to @DukeUrology @UroOnc PD and my mentor, Dr. @michaelabern, on receiving the Faculty Teaching Award 🏅
Tweet media one
Tweet media two
1
1
36
@alirezaghoreifi
Alireza Ghoreifi, MD
1 month
RT @GUconference: Bladder, kidney, prostate—#WorldGU25 covers it all. And with Dr. @michaelabern on the faculty, you know you’re getting th….
0
3
0
@alirezaghoreifi
Alireza Ghoreifi, MD
1 month
Great job by my colleagues @FarshadSheybaee @RKSayyid and the ROBUUST collaborative group!.
@UrolOncol
Urologic Oncology
1 month
📢Publication alert!. Highlights:.1⃣ypN+ #UTUC has worse OS vs pN+.2⃣ypN0 and pN0 pts have similar OS.3⃣All ypN+ pts experience metastasis within 1 year .4⃣89% of ypN+ vs 39% of pN+ have nodal/regional or distant Mets as initial site of recurrence. 🔗
Tweet media one
0
7
25
@alirezaghoreifi
Alireza Ghoreifi, MD
1 month
RT @alirezaghoreifi: Excited to see this special collection come together! If you're interested in contributing, feel free to DM/email me o….
0
2
0
@alirezaghoreifi
Alireza Ghoreifi, MD
1 month
RT @alirezaghoreifi: Honored and grateful to be recognized. @JUrology @AmerUrological @DukeUrology
Tweet media one
0
3
0